94557 ⎘
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
NANOMATERIALS
#2IONIZABLE LIPIDS FOR MULTIPLE ORGAN TARGETING
#3Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase
#4BIODEGRADABLE LIPIDS AND FORMULATIONS FOR DELIVERY OF MRNA
#5NOVEL B0AT1 INHIBITOR
#6Active Ingredients with Sialagogue and Tingling/Fizzy Effect, and Preparations Containing Same
#7IONIZABLE LIPIDS FOR MULTIPLE ORGAN TARGETING
#8NEW ALIPHATIC POLYAMINES FOR USE AS CURING AGENT FOR EPOXY RESINS
#9G-PROTEIN-COUPLED RECEPTOR REGULATORS AND METHODS OF USE THEREOF
#10ANTI-VIRAL COMPOUNDS
#11THERAPEUTIC COMPOUNDS AND COMPOSITIONS
#12NOVEL VDAC1 INHIBITORS
#13Diamine derivatives as inhibitors of leukotriene Ahydrolase
#14RADIO-AND CHEMO-PROTECTIVE COMPOUNDS
#15Methods and Compositions for Targeting Tregs using CCR8 Inhibitors
#16RADIO-PROTECTIVE AND CHEMO-PROTECTIVE SUBSTITUTED THIOLS
#17NAMPT MODULATORS
#18Lipid particle, composition comprising lipid particle, and method for delivering activators to cell
#19Methods and compositions for targeting Tregs using CCR8 inhibitors
#20ARYL HETEROCYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS
#21PHTHALAZINONE DERIVATIVES
#22Diamine Compound, Polyimide Precursor and Polyimide Film Using the Same, and Use Thereof
#23GEM-DISUBSTITUTED PYRROLIDINES, PIPERAZINES, AND DIAZEPANES, AND COMPOSITIONS AND METHODS OF MAKING THE SAME
#24Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists
#25Sulfonamideurea compounds
#26SMALL MOLECULES FOR CANCER THERAPY THAT REDUCE THE EXPRESSION OF TRANSCRIPTION FACTORS KLF5 AND EGR-1
#27GEM-DISUBSTITUTED PYRROLIDINES, PIPERAZINES, AND DIAZEPANES, AND COMPOSITIONS AND METHODS OF MAKING THE SAME
#28Radio-protective and chemo-protective substituted thiols
#29AMINE CATIONIC LIPIDS AND USES THEREOF
#30Phenyl-Piperazine Derivatives As Serotonin Reuptake Inhibitors
#31NANOMATERIALS
#32Therapeutic compounds and compositions
#33DAZA chelators as ligands in liver imaging
#34Methods for 1,4-diazo N-heterocycle synthesis
#35Diamine derivatives as inhibitors of leukotriene A4 hydrolase
#36Alcoxyamino derivatives for treating pain and pain related conditions
#37Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists
#38Selective ship inhibitors for treating disease
#39Biodegradable compound, lipid particle, composition comprising lipid particle, and kit
#40Viral replication inhibitors
#41Gem-disubstituted pyrrolidines, piperazines, and diazepanes, and compositions and methods of making the same
#42Bisaryl heterocycles as NRF2 activators
#43Phthalazinone derivatives
#44Therapeutic compounds and compositions
#45CHIRAL RESOLUTION OF AN INTERMEDIATE OF SUVOREXANT AND COCRYSTALS THEREOF
#46THERAPEUTIC COMPOUNDS AND COMPOSITIONS
#47PVC plasticizers and methods for making thereof
#48Substituted spirocyclohexanes as muscarinic Mreceptor and/or Mreceptor agonists
#49Dual NAV1.2/5HT2a inhibitors for treating CNS disorders
#50Amine cationic lipids and uses thereof
#51Methods for 1,4-diazo n-heterocycle synthesis
#52Suvorexant intermediate and preparation method thereof
#53Homopiperazine-based catalysts for neutralization of organophosphorus-based compounds
#54Azepane derivatives and methods of treating hepatitis B infections
#55Cyanopyridine derivatives as liver X receptor beta agonists, compositions, and their use
#56Bis(aminophenylphenol) ligands and transition metal catalysts prepared therefrom
#57Methods for low temperature fluorine-18 radiolabeling of biomolecules
#58Method for use of homopiperazinium compounds in the treatment of cancer
#59DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
#60Phthalazinone derivatives
#61Method of treating Crohn's disease comprising a TLR2 antagonist
#62N-aralkylcarbonyl-piperazine and -homopiperazine compounds and personal care compositions comprising the same
#63Phenyl-piperazine derivatives as serotonin reuptake inhibitors
#64Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists
#65Azepane derivatives and methods of treating hepatitis B infections
#66GLP-1 receptor modulators
#67DERIVATIVES OF BETULIN
#68GLP-1 receptor modulators
#69Homopiperazine-based catalysts for neutralization of organophosphorus-based compounds
#70Compounds and compositions for treating HIV with derivatives of Betulin
#71PHTHALAZINONE DERIVATIVES
#72Route of synthesis for the preparation of suvorexant
#73Method for use of homopiperazinium compounds in the treatment of cancer
#74Amine cationic lipids and uses thereof
#75Azepane derivatives and methods of treating hepatitis B infections
#76PIPERIDINE AND PIPERAZINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS AND CANCER
#77Viral replication inhibitors
#78Heterocyclic compounds and methods for their use
#79GLP-1 receptor modulators
#80GLP-1 receptor modulators
#81Phenyl-piperazine derivatives as serotonin reuptake inhibitors
#82Preparation and method for use in the treatment of respiratory diseases
#83Method of treating Ebola
#84Choline kinase inhibitors
#85Azepane derivatives and methods of treating hepatitis B infections
#86Azepane derivatives and methods of treating hepatitis B infections
#87Azepane derivatives and methods of treating hepatitis B infections
#88Sulfonamide derivative having PGD2 receptor antagonistic activity
#89Production method for isoquinoline derivatives and salts thereof
#90Trans-2-decenoic acid derivative and drug containing same
#91Therapeutic piperazines
#92Diamine derivatives as inhibitors of leukotriene A4 hydrolase
#93COMPOUNDS THAT TRAP ALPHA-OXOALDEHYDES AND ALPHA-BETA-UNSATURATED ALDEHYDES, META-COMPOUNDS CONTAINING SUCH COMPOUNDS, AND USE OF SAID COMPOUNDS IN TREATING ILLNESSES RELATED TO THE ACCUMULATION OF AGES AND ALES
#94GLP-1 receptor modulators
#95Class of diazepine derivative chelating agents and complexes with paramagnetic metals thereof as MRI contrast agents
#96GLP-1 receptor modulators
#97Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
#98Phenyl-piperazine derivatives as serotonin reuptake inhibitors
#99METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR
#100Cyclic amide BACE-1 inhibitors having a benzamide substituent
#101Sulfonyl-derivatives as novel inhibitors of histone deacetylase
#102PIPERAZINE PDE4 INHIBITORS AND USES THEREOF
#1032-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders
#1047-MEMBERED RING COMPOUND AND METHOD OF PRODUCTION AND PHARMACEUTICAL APPLICATION THEREOF
#105Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses
#106Transamination of nitrogen-containing compounds to make cyclic and cyclic/acyclic polyamine mixtures
#107Small molecule inhibitors of ebola and lassa fever viruses and methods of use
#1082,5-disubstituted arylsulfonamide CCR3 antagonists
#109Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor
#110Derivatives of betulin
#111GLP-1 receptor modulators
#112Production method for isoquinoline derivatives and salts thereof
#113DERIVATIVES OF AMINOINDANES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS
#114DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE
#115THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE
#116N-PHENYL-(PIPERAZINYL OR HOMOPIPERAZINYL)-BENZENESULFONAMIDE OR BENZENESULFONYL-PHENYL-(PIPERAZINE OR HOMOPIPERAZINE) COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR
#117Cyclic amine BACE-1 inhibitors having a benzamide substituent
#118Phenyl-piperazine derivatives as serotonin reuptake inhibitors
#119Diazepane acetamide derivatives as selective 11B-HSD1 inhibitors
#120Seven-membered ring compound and pharmaceutical use therefor
#121INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME
#122Glycine transporter-1 inhibitors
#123N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HTreceptor
#124METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR
#125Substituted arylamine compounds and methods of treatment
#126Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
#127Sulfonyl-derivatives as novel inhibitors of histone deacetylase
#128Cyclopropyl amide derivatives
#129Ligand libraries for screening GPCRs
#130N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
#131Nicotinic receptor agonists for the treatment of inflammatory diseases
#132Phthalazinone derivatives
#133Selective estrogen receptor modulator
#134SALICYLIC ACID DERIVATIVES BEING FARNESYL PYROPHOSPHATE SYNTHASE ACTIVITY INHIBITORS
#135Polyarylcarboxamides useful as lipid lowering agents
#1363-aminoalkyl-1,4-diazepan-2-one melanocortin-5-receptor antagonists
#137Contrast agents endowed with high relaxivity
#138Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
#1397-membered ring compound and method of production and pharmaceutical application thereof
#140Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses
#141DIPHENYL AZEPANE, DIAZEPANE AND OXAZEPANE DERIVATIVES AND USES THEREOF
#142Sirtuin modulating compounds
#143SUBSTITUTED AZEPINE- AND DIAZEPINE-SULFONAMIDES USEFUL TO INHIBIT 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1
#144Compounds
#145Heterocyclyl compounds
#146Therapeutic agent for Alzheimer's disease
#147Methods Of Coupling Multidentate AZA Ligands To Targeting Molecules
#148COMPOUNDS
#149Therapeutic piperazines
#150Piperazine PDE4 inhibitors and uses thereof
#151Therapeutic piperazines
#1523-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists
#153Substituted arylamide diazepinopyrimidone derivatives
#1541-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists
#155Probes, Systems, and Methods for Drug Discovery
#156Inhibitors of interleukin-1 beta converting enzyme
#157Amine-containing lipids and uses thereof
#158Phenyl-piperazine derivatives as serotonin reuptake inhibitors
#159Opsin-binding ligands, compositions and methods of use
#160Therapeutic compounds and compositions
#161Carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
#162Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HTreceptor
#163Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HTreceptor
#164Amide derivatives as positive allosteric modulators and methods of use thereof
#165N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HTreceptor
#166ANALGESIC THAT BINDS FILAMIN A
#167HETEROCYCLIC DERIVED METALLOPROTEASE INHIBITORS
#1682,5-disubstituted arylsulfonamide CCR3 antagonists
#169BUTYL AND BUTYNYL BENZYL AMINE COMPOUNDS
#170(THIO) Carbamoyl-Cyclohexane Derivatives as D3/D2 Receptor Antagonists
#171Sulfonyl-derivatives as novel or histone deacetylase
#172New Compounds
#173Diamine derivatives as inhibitors of leukotriene A4 hydrolase
#174HETEROCYCLIC SCAFFOLDS USEFUL FOR PREPARATION OF COMBINATORIAL LIBRARIES, LIBRARIES AND METHODS FOR PREPARATION THEREOF
#175Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders
#1761,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE AND 2,3,4,5-TETRAHYDROPYRROLO[1,2-a][1,4]-DIAZEPINE-7-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
#177Cyclic amine BACE-1 inhibitors having a benzamide substituent
#178HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN ATOMS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR TREATMENT OF CANCER
#179CYCLOHEXYL PIPERAZINYL METHANONE DERIVATIVES
#180Cyclopropane compounds and pharmaceutical use thereof
#181CATIONIC LIPIDS AND USES THEREOF
#182SULFONYLUREA DERIVATIVE CAPABLE OF SELECTIVELY INHIBITING MMP-13
#183Benzamide derivatives as bradykinin antagonists
#184SULFONAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS
#185SUBSTITUTED PIPERAZINES, (1,4) DIAZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS
#186Sulfonamide derivative having PGD2 receptor antagonistic activity
#187Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
#188Diazepane-acetamide derivatives as selective 11β-HSD1 inhibitors
#189Sulfonamide derivative having PGD2 receptor antagonistic activity
#190Hexafluoroisopropanol derivatives
#191Heterocyclyl compounds
#192Heterocyclyl compounds
#193Selective estrogen receptor modulator
#1942-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
#195Thiosemicarbazones as anti-virals and immunopotentiators
#196Peptide turn mimetics
#197N-benzyl,N'-arylcarbonylpiperazine derivatives
#198Cationic Lipids and Uses Thereof
#199NOVEL M3 MUSCARINIC ACETYLCHOINE RECEPTOR ANTAGONISTS
#2007-membered ring compound and method of production and pharmaceutical application thereof
#201Amide derivatives as positive allosteric modulators and methods of use thereof
#202Glycine transporter-1 inhibitors
#203Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor
#2043-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists
#205PARP INHIBITORS
#206Diaza heterocyclic amide compounds and their uses
#207Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors
#208Tartaric Acid Salts of a Dipeptidyl Peptidase-IV Inhibitor
#209SEROTONIN 5-HT3 RECEPTOR AGONIST
#2107-membered ring compound and method of production and pharmaceutical application thereof
#211HYDROXYALKANOYLAMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF A BETA PROTEIN PRODUCTION
#212NOVEL COMPOUNDS OF SUBSTITUTED AND UNSUBTITUTED ADAMANTYL AMIDES
#213Piperazine compounds
#214Cyclopropyl amide derivatives
#215Piperazine compounds
#216MMP-13 SELECTIVE INHIBITOR
#217CHEMICAL COMPOUNDS
#218Piperazine derivatives and methods of use
#219Cyclopropane compounds and pharmaceutical use thereof
#220Pharmaceutically Active Diazepanes
#221Muscarinic Receptor Antagonists
#222Bisbenzamidines for the Treatment of Pneumonia
#223Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof
#224CYCLOPROPANE COMPOUNDS AND PHARMACEUTICAL USE THEREOF
#225Ligands for G-Protein Coupled Receptors
#226Heterocyclic analgesic compounds and methods of use thereof
#227N-(3,4-disubstituted phenyl) salicylamide derivatives
#228Phthalazinone derivatives
#229Sulfonyl amino cyclic derivatives and use thereof
#230Ctgf Expression Inhibitor
#231Pyrroloquinoxalinone inhibitors of poly(ADP-ribose)polymerase
#232Amino-substituted tricyclic derivatives and methods of use
#233Substituted aryl cycloalkanoyl derivatives and methods of their use
#234Alkyl substituted homopiperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
#235Hydroxyalkanoylaminolactams and related structures as inhibitors of aβ protein production
#236POLYARYLCARBOXAMIDES USEFUL AS LIPID LOWERING AGENTS
#237Suppressor of excess accumulation of intracellular sodium ions
#238Substituted piperazines and diazepanes
#239Sulfonyl-derivatives as novel inhibitors or histone deacetylase
#240Heterocyclic derived metalloprotease inhibitors
#241Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
#242Aryl sulfonamide compounds for treating obesity
#243Adamantyl acetamides as 11-β hydroxysteroid dehydrogenase inhibitors
#244Inhibitors of interleukin-1β converting enzyme
#245SUBSTITUTED AMINOMETHYL BENZAMIDE COMPOUNDS
#2461-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists
#247Glycine transporter-1 inhibitors
#248Butyl and butynyl benzyl amine compounds
#249Serotonin 5-HT3 receptor agonist
#250Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (MRI) which contain a chelating moiety with polyhydroxylated substituents
#251Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
#252Diaza heterocyclic amide compounds and their uses
#2532-alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
#254Viral polymerase inhibitors
#255N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
#256Therapeutic piperazines
#257Diaza heterocyclic sulfonamide derivatives and their uses
#258Cyclohexyl piperazinyl methanone derivatives
#259Amide inhibitors of leukotriene A4 hydrolase
#260Diamine derivatives as inhibitors of leukotriene Ahydrolase
#2612-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
#262Sulfonyl-derivatives as novel inhibitors of histone deacetylase
#263Tachykinin Antagonists
#264Polyarylcarboxamides useful as lipid lowering agents
#265Substituted naphthalene sulfonamides
#266New compounds
#267Compounds
#268Bioisosteres of actinonin
#269Phenyl-piperazine derivatives as serotonin reuptake inhibitors
#270Dipiperazinyl ketones and related analogues
#271Sirtuin modulating compounds
#272Sirtuin modulating compounds
#273Derivatives of alkylpiperazine and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors
#274Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
#275Heterocyclylakylamines as muscarinic receptor antagonists
#2761,2-di(cyclic) substituted benzene compounds
#277Polyarylcarboxamides useful as lipid lowering agents
#278Piperazine compounds
#279Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
#280(Thio) carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists
#281Substituted arylamine compounds and methods of treatment
#282Cyclopropane compounds and pharmaceutical use thereof
#283Compounds for the treatment of inflammatory disorders
#284Urea inhibitors of MAP kinases
#285Inhibitors for excessive accumulation of sodium ion in cells
#286Ureas as factor Xa inhibitors
#287N,N-disubstituted diazocycloalkanes
#288Diazepanes derivatives useful as IFA inhibitors
#289Para-phenylenediamine derivatives comprising a cyclic diaza group substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers
#290Selective estrogen receptor modulator
#291Phenyl-piperazine derivatives as serotonin reuptake inhibitors
#292Phenyl-piperazine derivatives as serotonin reuptake inhibitors
#293Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
#294IL-8 receptor antagonists
#295Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
#296Aryloxyalkylamine derivatives as h3 receptor ligands
#297Arylamines for the treatment of conditions associated with gsk-3
#298Haloperidol analogs
#299Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
#300Substituted piperazines,(1,4) diazepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists